Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.5385
$0.01853.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.11M | -28.92M | -29.92M | -33.01M | -35.99M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.08M | 1.86M | 912.60K | 671.10K | 606.70K |
| Change in Net Operating Assets | -1.52M | -2.95M | -4.54M | -976.50K | 130.20K |
| Cash from Operations | -26.55M | -30.01M | -33.54M | -33.32M | -35.26M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 561.90K | 561.90K | 976.90K | 415.00K | 415.00K |
| Total Debt Repaid | -656.30K | -669.70K | -518.80K | -554.50K | -430.00K |
| Issuance of Common Stock | 30.83M | 23.44M | 23.19M | 34.05M | 30.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.73M | 23.33M | 23.65M | 33.91M | 30.28M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.19M | -6.68M | -9.89M | 586.50K | -4.97M |